Ensign Peak Advisors, Inc Biolife Solutions Inc Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$14.64 - $26.7 $19,617 - $35,778	-1,340 Reduced 10.36%	11,590 $264,000
Q1 2022 May 16, 2022	SELL	$20.81 - $37.29 $260,124 - $466,125	-12,500 Reduced 49.15%	12,930 $294,000
Q4 2021 Feb 11, 2022	SELL	$32.99 - $58.55 $345,405 - $613,018	-10,470 Reduced 29.16%	25,430 $948,000
Q3 2021 Nov 12, 2021	BUY	$42.03 - $60.5 $983,502 - $1.42 Million	23,400 Added 187.2%	35,900 $1.52 Million
Q1 2021 May 12, 2021	BUY	$32.95 - $44.24 $411,875 - $553,000	12,500 New	12,500 $450,000

188

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.12B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.